May 8, 2018 / 11:12 AM / 5 months ago

BRIEF-Sangamo Therapeutics Reports Q1 Loss Per Share Of $0.23

May 8 (Reuters) - Sangamo Therapeutics Inc:

* SANGAMO THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.23

* Q1 EARNINGS PER SHARE VIEW $0.48 — THOMSON REUTERS I/B/E/S

* SAYS EXPECTS THAT OPERATING EXPENSES WILL BE IN RANGE OF $140 MILLION TO $150 MILLION FOR YEAR-END 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below